Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study

被引：0

作者：

Yuichi Ohashi

Masahiro Munesue

Jun Shimazaki

Etsuko Takamura

Norihiko Yokoi

Hitoshi Watanabe

Akio Nomura

Fumiki Shimada

机构：

[1] Ehime University,School of Medicine

[2] Santen Pharmaceutical Co.,undefined

[3] Ltd,undefined

[4] Tokyo Dental College Ichikawa General Hospital,undefined

[5] Tokyo Women’s Medical University,undefined

[6] Kyoto Prefectural University of Medicine,undefined

[7] Kansai Rosai Hospital,undefined

来源：

Advances in Therapy | 2020年 / 37卷

关键词：

Break-up time; Diquafosol; Dry eye; Fluorescein staining; Ophthalmology; Post-marketing study; Safety;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：707 / 717

页数：10

共 50 条

[31] Treatment Patterns and Satisfaction in Dry Eye Patients in Real-World Practice Setting
Dubey, A.
Patel, V. D.
Walt, J. G.
Fox, K. M.
Schwartz, M.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
[32] Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye
Koh, Shizuka
Ikeda, Chikako
Takai, Yoshihiro
Watanabe, Hitoshi
Maeda, Naoyuki
Nishida, Kohji
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2013, 57 (05) : 440 - 446
[33] Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye
Shizuka Koh
Chikako Ikeda
Yoshihiro Takai
Hitoshi Watanabe
Naoyuki Maeda
Kohji Nishida
Japanese Journal of Ophthalmology, 2013, 57 : 440 - 446
[34] Retrospective Observational Study to Evaluate Long-Term Effectiveness and Safety of Omalizumab Treatment in Real-Life Setting in Allergy Centre of Spain
Marquez Hernandez, Dorkas Margarita
Bastidas, Jose A.
Herraez, Lys
Mederos, Elena
Enriquez Matas, A.
Mielgo Ballesteros, Ruth
Fernandez, Consuelo
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB12 - AB12
[35] Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany
Ziemssen, Tjalf
Lang, Michael
Schmidt, Stephan
Albrecht, Holger
Klotz, Luisa
Haas, Judith
Lassek, Christoph
Lang, Stefan
Winkelmann, Veronika E.
Ettle, Benjamin
Schulze-Topphoff, Ulf
JOURNAL OF NEUROLOGY, 2022, 269 (06) : 3276 - 3285
[36] Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany
Tjalf Ziemssen
Michael Lang
Stephan Schmidt
Holger Albrecht
Luisa Klotz
Judith Haas
Christoph Lassek
Stefan Lang
Veronika E. Winkelmann
Benjamin Ettle
Ulf Schulze-Topphoff
Journal of Neurology, 2022, 269 : 3276 - 3285
[37] Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)
Butzkueven, Helmut
Kappos, Ludwig
Wiendl, Heinz
Trojano, Maria
Spelman, Tim
Chang, Ih
Kasliwal, Rachna
Jaitly, Seema
Campbell, Nolan
Ho, Pei-Ran
Licata, Stephanie
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2020, 91 (06): : 660 - 668
[38] The real-world long-term effectiveness of vedolizumab in inflammatory bowel diseases: a single-centre observational study
Macaluso, F. S.
Croce, A.
Orlando, R.
Ventimiglia, M.
Sapienza, C.
Gambino, F.
Orlando, E.
Grova, M.
Rizzuto, G.
Renna, S.
Cottone, M.
Orlando, A.
JOURNAL OF CROHNS & COLITIS, 2019, 13 : S472 - S473
[39] Long-term persistence with mirabegron in a real-world clinical setting
Wada, Naoki
Watanabe, Masaki
Banjo, Hiroko
Tsuchida, Miyu
Hori, Junichi
Tamaki, Gaku
Azumi, Makoto
Kita, Masafumi
Kakizaki, Hidehiro
INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (05) : 501 - 506
[40] Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study
Caroline Papeix
Giovanni Castelnovo
Emmanuelle Leray
Marc Coustans
Pierre Levy
Jean-Marc Visy
Gisela Kobelt
Fabienne Lamy
Bashar Allaf
François Heintzmann
Isabelle Chouette
Eric Raponi
Barbara Durand
Emmanuelle Grevat
Driss Kamar
Marc Debouverie
Christine Lebrun-Frenay
Neurology and Therapy, 2022, 11 : 633 - 658

← 1 2 3 4 5 →